Anal Cancer Rates Higher in People With HIV Than in HIV-Negatives
HIV-positive people had a higher rate of new anal cancer than HIV-negative people in a comparison involving thousands of people in the United States and Canada.1 HIV-positive gay and bisexual men had more than an 80 times higher anal cancer rate than HIV-negative people in this study.
Because strong antiretroviral combinations that HIV-positive people started taking in the 1990s greatly lowered the AIDS death rate, a growing proportion of people with HIV now die of cancer, especially cancers caused by infections. Anal cancer can be caused by human papillomavirus (HPV) infection in men and women. Like HIV, HPV can pass from one person to another during sex, so many people with HIV also have HPV. In the United States, 2700 women and 1500 men get HPV-related anal cancer every year.2
Previous large studies found that HIV-positive people have a 30 times higher anal cancer rate than the general population.3,4 But anal cancer incidence -- the rate of newly diagnosed cancers in a given period -- has varied widely from study to study. Gay and bisexual men have the highest anal cancer rates in these studies, but it's unclear how anal cancer rates differ in gay men, straight men, and women with HIV when compared with HIV-negative people.
To learn more about anal cancer rates in different groups of HIV-positive people, U.S. and Canadian researchers planned this new study.
How the Study Worked
The study involved HIV-positive men and women who were members of 10 U.S. and 3 Canadian HIV study groups from 1996 through 2007. A comparison group of HIV-negative men and women came from 3 of the 10 U.S. study groups. The analysis did not include anyone who already had anal cancer when they entered their study group.
Researchers counted the number of new anal cancers detected (anal cancer incidence) during the study period. The main goal of the study was to estimate anal cancer incidence in three HIV-positive groups: gay and bisexual men, "other men" who became infected with HIV during sex with women or when injecting drugs, and women.
The researchers used standard statistical methods to compare anal cancer incidence in these groups with incidence in HIV-negative men and women according to year (1996-1999, 2000-2003, and 2004-2007), age (in 5-year groups), and race or ethnicity. They also figured how cancer incidence changed in these groups through the three study periods (1996-1999, 2000-2003, and 2004-2007).
In addition, the research team analyzed anal cancer incidence in the HIV-positive groups by calculating standardized incidence ratios. This statistic compared anal cancer rates in the HIV-positive groups with rates in a nationwide U.S. database called SEER (for Surveillance, Epidemiology, and End Results). This analysis accounted for the potential impact of age and race or ethnicity on cancer rates. The researchers conducted this analysis because the HIVnegative group in the main comparison included people from only 3 of the 10 study groups -- and the research team wanted to make sure that comparison was accurate.
What the Study Found
The study involved 18,855 HIV-positive gay or bisexual men (55% of the HIV group), 6492 other HIV-positive men (19% of the HIV group), and 8842 HIV-positive women (26% of the HIV group). The comparison group had 102,607 HIVnegative men and 11,653 HIV-negative women.
Median age was similar across all of these groups at about 38 years. Whites made up 63% of the gay/bisexual HIV group, while blacks made up 52% of the other HIV-positive men and 54% of HIV-positive women. Among HIV-positive women and other men with HIV, about 60% picked up HIV during sex.
Anal cancer incidence (the new diagnosis rate) per 100,000 person-years was 131 for HIV-positive gay/bisexual men, 46 for HIV-positive other men, 30 for HIV-positive women, and 2 for HIV-negative men. Anal cancer developed in no HIV-negative women during the study period. Compared with HIV-negative men, HIV-positive gay/bisexual men had an 80.3 times higher rate of new anal cancer and HIV-positive other men had a 26.7 times higher rate.
For HIV-positive gay/bisexual men, other men, and women, anal cancer incidence was lowest in 1996-1999, the first years of the combination antiretroviral therapy era (Figure 1). The new anal cancer rate rose sharply in 2000-2003 and remained at about that level in 2004-2007.
Another analysis compared the new anal cancer rate in the three HIV-positive groups with the rate in a large U.S. national database (Table 1). This analysis showed much higher anal cancer rates in the HIV-positive groups than in the general population. The anal cancer rate difference between the HIVpositive groups and the general U.S. population was highest for gay or bisexual men.
Finally, statistical analysis that figured in the impact of several cancer risk factors found a significant difference in risk of new anal cancer in the following groups:
- HIV gay/bisexual men versus other HIV-positive men: 3.3 times higher risk
- Every additional 10 years of age: 30% higher risk
- People cared for in 1996-2003 versus 2000-2003: 50% lower risk
- People of nonwhite race or ethnicity versus whites: 70% lower risk
- People with CD4 count at or above 500 versus below 200: 80% lower risk
What the Results Mean for You
This large U.S.-Canadian study found that HIV-positive people have higher rates of new anal cancer than HIV-negative people or people in the general population. The comparative rate is highest for HIV-positive gay or bisexual men, who have over an 80 times higher new anal cancer rate than HIV-negative people.
The anal cancer rate rose sharply from 1996-1999 (the first years of the combination antiretroviral era) to 2000-2003. That high rate remained about the same in 2004-2007.
The higher anal cancer rate in HIV-positive people than in HIV-negative people is not surprising because both HIV and HPV (which can cause anal cancer) can be passed from one sex partner to another. People with many sex partners and people who don't use condoms during sex run a high risk of getting infected with HIV or HPV.
Always wearing a condom during anal or vaginal sex greatly lowers the risk of HIV or HPV infection. There are also vaccines to protect people from HPV infection. The CDC recommends the vaccine Cervarix or Gardasil for all 11- and 12-year-old girls and for all girls and women from 13 to 26 years old who did not get any or all of the three vaccine shots when they were younger.2 Gardasil is available for boys and men from 9 through 26 years of age. Research must determine whether these vaccines will prevent anal cancer in people with HIV.
The American Cancer Society lists the following risk factors for anal cancer: HPV infection, HIV infection, many sex partners, receptive anal intercourse, smoking, low CD4 count, and previous cancer of the cervix, vagina, or vulva.5 At the link provided at reference 5 below, the American Cancer Society offers helpful online information explaining anal cancer, its causes, risk factors, and prevention, early detection, and treatment.
Anal cancer can be detected early with a digital rectal exam. A Pap test can detect anal cancer or cell changes that may develop into anal cancer. The New York State AIDS Institute recommends yearly digital rectal exams for all HIV-positive people and Pap testing for (1) gay or bisexual men, (2) people who have had anal or genital warts, and (3) women with abnormal cells in the cervix or vulva.6 The researchers who conducted this study1 note that further research is needed to determine whether this approach will lower anal cancer rates in people with HIV.
The U.S.-Canadian research team believes their results suggest that anal cancer prevention efforts should be aimed at all people with HIV infection, not selected groups.
- Silverberg MJ, Lau B, Justice AC, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012;54:1026-1034.
- Centers for Disease Control and Prevention. Sexually Transmitted Diseases. Genital HPV infection -- fact sheet.
- Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67.
- Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52:611-622.
- American Cancer Society. Learn about cancer: Anal cancer.
- New York State Department of Health AIDS Institute. Neoplastic complications of HIV infection. July 2007.